The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells

British Journal of Haematology

Volumn 100, Issue 4, 1998, Pages 637-646

  Jourdan, Michel ^a   Ferlin, Martine ^b   Legouffe, Eric ^c   Horvathova, Mira ^a   Liautard, Janny ^a   Rossi, Jean François ^c   Wijdenes, John ^d   Brochier, Jean ^a   Klein, Bernard ^a,b,c  

^a INSERM   (France)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^c HÔPITAL SAINT ELOI   (France)

^d Diaclone   (France)

Author keywords

Apoptosis; Interleukin 6; Multiple myeloma; Plasmocyte; Syndecan 1

Indexed keywords

CD38 ANTIGEN; DEXAMETHASONE; GLYCOPROTEIN GP 130; HLA ANTIGEN CLASS 1; INTERLEUKIN 6; MONOCLONAL ANTIBODY; SYNDECAN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADP-RIBOSYL CYCLASE; ANNEXIN A5; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CELL DIVISION; CYTOKINE RECEPTOR GP130; DEXAMETHASONE; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; MULTIPLE MYELOMA; NAD+ NUCLEOSIDASE; PROTEOGLYCANS; SYNDECAN-1; SYNDECANS; TUMOR CELLS, CULTURED;

EID: 0031929051     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00623.x     Document Type: Article

References (29)

1. Attal, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. & Bataille, R. (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. New England Journal of Medicine, 335, 91-97.
2. Barlogie, B. (1997) Advances in multiple myeloma treatment: biology and therapy. American Society of Clinical Oncology: Educational Book (ed. by M. C. Perry), pp. 123-134. American Society of Clinical Oncology, Alexandria.
3. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.L. & Lose, E.J. (1992) Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annual Review of Cell Biology, 8, 365-393.
4. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood, 84, 1421-1426.
5. Clement, C., Vouijs, W.C., Klein, B. & Wijdenes, J. (1995) B-B2 and B-B4, two new mAb against secreting plasma cells. Leucocyte Typing V (ed. by Schlossman et al ), pp. 714-715. Oxford University Press.
6. Collins, M.K.L., Marvel, J., Malde, P. & Lopez-Rivas, A. (1992) Interleukin-3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. Journal of Experimental Medicine, 176, 1043-1051.
7. Harada, H., Kawano, M.M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H. & Kuramoto, A. (1993) Phenotypic difference of normal plasma cells from mature myeloma cells. Blood, 81, 2658-2663.
8. Homburg, C.H.E., De Haas, M., von dem Borne, A.E.G.Kr., Verhoeven, A.J., Reutelingsperger, C.P.M. & Roos, D. (1995) Human neutrophils lose their surface Fc gamma RIII and acquire annexin V binding sites during apoptosis in vitro. Blood, 85, 532-540.
9. Horvathova, M., Gaillard, J.P., Liautard, J., Duperray, C., Lavabre-Bertrand, T., Bourquard, P., Rossi, J.F., Klein, B. & Brochier, J. (1995) Identification of novel and specific antigens of human plasma cells by mAb. Leucocyte Typing V (ed. by Schlossman et al ), pp. 713-714. Oxford University Press.
10. Ihrcke, N.S. & Platt, J.L. (1996) Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. Journal of Cellular Physiology, 168, 625-637.
11. Inki, P. & Jalkanen, M. (1996) The role of syndecan-1 in malignancies. Annals of Medicine, 28, 63-67.
12. Kiefer, M.C., Stephans, J.C., Crawford, K., Okino, K. & Barr, P.J. (1990) Ligand-affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor. Proceedings of the National Academy of Sciences of the United States of America, 87, 6985-6989.
13. Kishimoto, T., Goyert, S., Kikutani, H., Mason, D., Miyasaka, M., Moretta, L., Ohno, T., Okumura, K., Shaw, S., Springer, T.A., Sugamura, K., Sugawara, H., von dem Borne, A.E. & Zola, H. (1997) CD antigens 1996. Blood, 89, 3502.
14. Klein, B., Zhang, X.G., Rossi, J.F. (1997) Cytokines and cytokine receptors and signal transduction in human multiple myeloma. In: Myeloma: Biology and Management (ed. by J. C. Malpas et al). Oxford University Press.
15. + cells to remove circulating tumor cells. Blood, 87, 1625-1634.
16. Liautard, J., Sun, R.X., Cotte, N., Gaillard, J.P., Mani, J.C., Klein, B. & Brochier, J. (1997) Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor. Cytokine, 9, 233-241.
17. Numa, F., Hirabayashi, K., Tsunaga, N., Kato, H., O'Rourke, K., Shao, H., Stechmann-Lebakken, C., Varani, J., Rapraeger, A. & Dixit, V.M. (1995) Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells. Cancer Research, 55, 4676-4680.
18. Pulkkinen, J.O., Penttinen, M., Jalkanen, M., Klemi, P. & Grenman, R. (1997) Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngologica, 117, 312-315.
19. Reiland, J., Ott, V.L., Lebakken, C.S., Yeaman, C., McCarthy, J. & Rapraeger, A.C. (1996) Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1. Biochemical Journal, 319, 39-47.
20. Ridley, R.C., Xiao, H., Hata, H., Woodliff, J., Epstein, J. & Sanderson, R.D. (1993) Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood, 81, 767-774.
21. + peripheral blood progenitor cells after double high dose chemotherapy in multiple myeloma is followed by severe immunodeficiency and high production of interleukin-6 related-C reactive protein requiring additive immunotherapy. (Abstract). Blood, 88, 132a.
22. Subramanian, S.V., Fitzgerald, M.L. & Bernfield, M. (1997) Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. Journal of Biological Chemistry, 272, 14713-14720.
23. + malignant plasma cells. Journal of Immunological Methods, 205, 73-79.
24. Tricot, G., Vesole, D.H., Jagannath, S., Hilton, J., Munshi, N. & Barlogie, B. (1996) Graft-versus-myeloma effect: proof of principle. Blood, 87, 1196-1198.
25. Verdonck, L.F., Lokhorst, H.M., Dekker, A.W., Nieuwenhuis, H.K. & Petersen, E.J. (1996) Graft-versus-myeloma effect in two cases. Lancet, 347, 800-801.
26. Vermes, I., Haanen. C., Steffens-Nakken, H. & Reutelingsperger, C. (1995) A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. Journal of Immunological Methods, 184, 39-51.
27. Wijdenes, J., Clément, C., Klein, B. & Dore, J.-M. (1997) CD138 cluster report. In: Leucocyte Typing VI (ed. by Kishimoto et al). Garland, New York.
28. Wijdenes, J., Vooijs, W.C., Clement, C., Post, J., Morard, F., Vita, N., Laurent, P., Sun, R.X., Klein, B. & Dore, J.M. (1996) A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. British Journal of Heamatology, 94, 318-323.
29. Zhang, X.G., Gaillard, J.P., Robillard, N., Lu, Z.Y., Gu, Z.J., Jourdan, M., Boiron, J.M., Bataille, R. & Klein, B. (1994) Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood, 85, 3654-3663.